/PRNewswire/ -- Amgen (NASDAQ:AMGN) and Horizon Therapeutics plc (NASDAQ:HZNP) today announced the entry into a consent order agreement with the Federal Trade...
It looks like the Federal Trade Commission will give up on its attempt to block Amgen's acquisition of Horizon Therapeutics.
Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.45%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.59%. Stock indexes this morning are moderately higher on some...
The biotech checks several important boxes for long-term shareholders.
Its pending acquisition of Horizon Therapeutics could make the company much bigger.
Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.65%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.61%. Stock indexes this morning are moderately lower. Weakness...
The markets have been on fire the past couple of weeks. While yesterday’s interest hike took some steam out of the markets, these three stocks and their options are unusually active and worthy of consideration. ...
The company announced preliminary trial results for its lead therapy.
The biotech could pursue these two budget-friendly targets.
Already under fire on the regulatory front, the company is hit with a price-target cut.